Literature DB >> 23178625

A practical scoring system for predicting cirrhosis in patients with chronic viral hepatitis.

Jae Youn Cheong1, Soon Ho Um, Yeon Seok Seo, Seung Soo Shin, Rae Woong Park, Dong Joon Kim, Seong Gyu Hwang, Youn Jae Lee, Mong Cho, Jin Mo Yang, Young Bae Kim, Young Nyun Park, Sung Won Cho.   

Abstract

BACKGROUND/AIMS: The purpose of the current study was to develop a simple model for predicting cirrhosis in chronic viral hepatitis patients and to evaluate the usefulness of decision tree algorithms.
METHODOLOGY: Serum markers of fibrosis were compared with the stage of fibrosis in liver biopsy specimens prospectively obtained from 526 subjects with chronic HBV and HCV infections (estimation set, 367; validation set, 159).
RESULTS: Univariate analysis revealed that age, bilirubin, platelet count, APRI, ALP, hyaluronic acid (HA), α2-macroglobulin, MMP-2, TIMP-1, and procollagen III N-terminal peptide (PIIINP) were significantly different between patients with (F4) and without cirrhosis (F0123). Multivariate logistic regression analysis identified platelet count, HA and PIIINP as independent predictors of cirrhosis. We categorized the individual variable into the most appropriate cut-off value by calculating the likelihood ratio for predicting cirrhosis and constructed a score system expressed by the following simple formula: PHP index = platelet score + HA score + PIIINP score. For predicting cirrhosis, the area under the receiver operating characteristic curve (AUROC) was 0.824 and 0.759 in the estimation and validation set, respectively. Using a cut-off score of 4, the presence of cirrhosis was predicted with high accuracy. The diagnostic performance of the PHP index was similar to decision tree algorithms (AUROC=0.819) for predicting liver cirrhosis, but more useful in clinical situations.
CONCLUSIONS: Compared to a decision tree model, a simple score system using a categorized value based on a combination of platelet count, HA and PIIINP identified patients with liver cirrhosis with a higher clinical usability.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23178625     DOI: 10.5754/hge10157

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  3 in total

1.  The Role of M30 in Predicting the Severity of Liver Fibrosis and Inflammation in Chronic Hepatitis B Patients.

Authors:  Baris Yilmaz; Bora Aktas; Akif Altinbas; Zeynep Ginis; Gulfer Ozturk; Fuat Ekiz; Serta Kilincalp; Murat Deveci; Zahide Simsek; Sahin Coban; Omer Basar; Osman Yuksel
Journal:  Hepat Mon       Date:  2016-08-10       Impact factor: 0.660

2.  Therapeutic efficacy of fuzheng-huayu tablet based traditional chinese medicine syndrome differentiation on hepatitis-B-caused cirrhosis: a multicenter double-blind randomized controlled trail.

Authors:  Ya-Nan Song; Ji-Jia Sun; Yi-Yu Lu; Lie-Ming Xu; Yue-Qiu Gao; Wei Zhang; Xiao-Su Wang; Dong-Ying Xue; Qing-Shan Zheng; Shi-Bing Su
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-06       Impact factor: 2.629

3.  Can We Predict Individual Combined Benefit and Harm of Therapy? Warfarin Therapy for Atrial Fibrillation as a Test Case.

Authors:  Guowei Li; Lehana Thabane; Thomas Delate; Daniel M Witt; Mitchell A H Levine; Ji Cheng; Anne Holbrook
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.